Abstract:You have accessJournal of UrologyKidney Cancer: Localized: Ablative Therapy1 Apr 2018PD61-02 FEASIBILITY AND ONCOLOGIC OUTCOMES OF MICROWAVE ABLATION WITH RENAL TUMORS: A RETROSPECTIVE STUDY OF INTERMEDIATE-TERM FOLLOW-UP RESULTS Baoan Hong, Yong Yang, Ning Zhang, and Kan Gong Baoan HongBaoan Hong More articles by this author , Yong YangYong Yang More articles by this author , Ning ZhangNing Zhang More articles by this author , and Kan GongKan Gong More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2018.02.2826AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES In recent years, the mainstream for management of renal tumors has rapidly developed from traditional open surgery to laparoscopic or robot-assisted nephron-sparing surgery. Local ablative techniques are the further development towards minimally invasive treatment for renal tumors. The international guidelines recommend that thermal ablation is a treatment alternative in high-risk surgical candidates. The present study aimed to evaluate the feasibility and oncologic outcomes of microwave ablation (MWA) with renal tumors. METHODS A total of seventeen patients with renal tumors received either ultrasound-guided percutaneous or laparoscopic-assisted MWA treatment. According to the tumor size, single or double needles were simultaneously used and the patients were ablated with different power/time combinations. The patients were followed up with abdominal ultrasound or enhanced CT examination and renal function test at 1, 3 months, and every 6-12 months thereafter. The patients physical status and related complications were closely observed. RESULTS Seven patients received ultrasound-guided MWA and ten patients underwent laparoscopic-assisted MWA. The postoperative follow-up averaged 45 months (39-53 months). One patient occurred the complication of urine leakage but was cured by indwelling ureteral stents for about three months. Two patients died of tumor recurrence and one patient died of severe lung infection. For other patients, postoperative imaging did not find abnormalities. There were no significant changes on renal function before and after the operation. The procedures of MWA were well tolerated in the patients with multiple comorbidities and improved their quality of life. CONCLUSIONS Safety and effectiveness of MWA with renal tumors is favorable. It is a promising technique for the treatment of renal tumors. Importantly, the patients condition and tumor features should be taken into full account. © 2018FiguresReferencesRelatedDetails Volume 199Issue 4SApril 2018Page: e1152 Advertisement Copyright & Permissions© 2018MetricsAuthor Information Baoan Hong More articles by this author Yong Yang More articles by this author Ning Zhang More articles by this author Kan Gong More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...

Ultrasound guided percutaneous microwave ablation treatment for renal carcinomas at T1a stage: the safety evaluation in clinical application

A multicenter 10-year oncologic outcome of ultrasound-guided percutaneous microwave ablation of clinical T1 renal cell carcinoma: will it stand the test of time?

Computed tomography (CT)-guided percutaneous coaxial biopsy combined with microwave ablation for the treatment of renal masses

PD61-02 FEASIBILITY AND ONCOLOGIC OUTCOMES OF MICROWAVE ABLATION WITH RENAL TUMORS: A RETROSPECTIVE STUDY OF INTERMEDIATE-TERM FOLLOW-UP RESULTS

Safety and Effectiveness Analysis of Percutaneous Microwave Thermal Ablation Therapy Combined Brachytherapy for Lung Malignant Lesion

Percutaneous microwave ablation of T1a renal cell carcinomas: A 10‐year single‐center retrospective review

Efficacy and safety of MWA versus RFA and CA for renal tumors: A systematic review and meta-analysis of comparison studies

Thermal Ablation Assisted Laparoscopic Partial Nephrectomy for Clinical T1b Renal Tumors.

Clinical Study on the Efficacy of Microwave Ablation (MA) in the Treatment of Stage I Renal Clear Cell Carcinoma by CT and MRI Imaging

[Safety and Efficacy of Laparoscopic Microwave Ablation Combined with Partial Nephrectomy for Renal Tumors: Initial Experience].

Feasibility and safety study of ultrasound-guided percutaneous microwave ablation for Sub-cardiac liver cancers without artificial ascites assistance

Update of percutaneous microwave ablation for renal cell carcinoma

[Ultrasound-Guided Percutaneous Radiofrequency Ablation Treatment for Renal Clear Cell Carcinoma].

The Efficacy and Safety of Microwave Ablation in Patients with Retroperitoneal Metastases

Image-guided percutaneous microwave ablation for unresectable pancreatic cancers: A multicenter retrospective study

Correlations of RENAL, PADUA and NePhRO Scores with Complications and Outcomes in Patients after CT-Guided Microwave Ablation of Renal Tumors.

Short-Term Outcomes and Safety of Computed Tomography-Guided Percutaneous Microwave Ablation of Solitary Adrenal Metastasis from Lung Cancer: A Multi-Center Retrospective Study

Percutaneous cool-tip radiofrequency ablation for T_(1a) renal cell carcinoma

Percutaneous Microwave Ablation of Stage I Medically Inoperable Non‐small Cell Lung Cancer: Clinical Evaluation of 47 Cases

The Safety and Efficacy of Laparoscopic Microwave Ablation-Assisted Partial Nephrectomy: a New Avenue for the Treatment of Cystic Renal Tumors

Percutaneous Application of High Power Microwave Ablation With 150 W for the Treatment of Tumors in Lung, Liver, and Kidney: A Preliminary Experience